Bifidobacterium animalis H22B621
Bifidobacterium animalis H22B621 has one identified study in the indexed literature: a 2026 animal model investigation examining a postbiotic (fermented product) derived from this strain in relation to lipid metabolism parameters in mice exposed to microplastics. This is a single preclinical study and cannot be extrapolated to human health outcomes. Strain-specific evidence for H22B621 is very limited; species-level evidence for Bifidobacterium animalis does not confer strain-specific claims. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 1 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
1 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →Postbiotic from Bifidobacteria-Fermented Tomato Juice Alleviates Lipid Metabolism Disorders Caused by Microplastics· Food Science and Human Wellness · 2026